GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of tirzepatide — 22 things I got wrong before I got it right — 22 comments in the full submission. View in context.
6.6k
c/tirzepatide·submitted 5 months ago by u/sofia_nascimento

tirzepatide — 22 things I got wrong before I got it right

Resultsbranch of 6 comments

tirzepatide — 22 things I got wrong before I got it right. I have gone back and forth on this for months. The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to. It is a dual GIP and GLP-1 receptor…

Read the full submission and all 22 comments →

This branch

6 comments, started 5 months ago
u/tove_vasquez163 points·5 months ago

I would separate the two claims. That the GIP arm exists is uncontroversial; that it explains your fatigue pattern is a guess.

replysharereportpermalink
u/bastian_ekstrom237 points·5 months ago

Came off sema and onto tirz with a two-week gap. The first month was flat and I assumed I had made a mistake. Month two it moved.

replysharereportpermalink
u/sten_palacios115 points·5 months ago

if 7.5 is working, 10 is not automatically better

replysharereportpermalink
u/laila_yilmaz59 points·5 months ago

switching from sema is not a dose conversion, there is no clean equivalence

replysharereportpermalink
u/throwaway_titration79 points·5 months ago

I would separate the two claims.

tove_vasquez is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.

replysharereportpermalink
u/aurel_lindqvist50 points·5 months ago

pens and vials are the same molecule, the price is the difference

replysharereportpermalink

← back to the whole thread

About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

Janoshik Analytical

Independent HPLC and mass spec. The number you get is the number they found.

janoshik.comSponsored

GL Biochem (Shanghai)

Custom peptides and amino acids direct from the manufacturer since 1998. ISO 9001 / cGMP. Batch COA every order.

glbiochem.net
More in c/tirzepatide
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/titration_marshalu/incretin_ivyu/quiet_moderatoru/dexa_twice_yearly
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →